Life Technologies Corporation
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2012-10-31
- Valid until
- still holds
- Published
- 2012-10-31
- Recorded by AsOf
- 2026-11-17
- Checked
- 2026-11-19 · its source page states the value and the date, as read by an AI model
- Confidence
- 0.70
Sources
“SANTA CLARA, CA -- NVIDIA® Tesla® GPU accelerators are enabling Life Technologies Corporation's new Ion Proton™ System to accelerate primary genome-sequence analysis -- the computation that generates DNA base pairs -- by over 16 times.”— what the page says, read 2026-11-19
Cite this claim
Plain text
AsOf. "Nvidia partnership: Life Technologies Corporation", as of 2012-10-31. Claim clm_9617DFAFDF30, https://asof.is/claim/clm_9617DFAFDF30, accessed 2026-11-20. Source: https://nvidianews.nvidia.com/news/new-gene-sequencer-to-break-1-000-cost-barrier-with-nvidia-tesla-gpu-acceleration.
APA
AsOf. (2012). Nvidia partnership: Life Technologies Corporation (as of 2012-10-31) [Record clm_9617DFAFDF30]. Retrieved November 20, 2026, from https://asof.is/claim/clm_9617DFAFDF30 (source: https://nvidianews.nvidia.com/news/new-gene-sequencer-to-break-1-000-cost-barrier-with-nvidia-tesla-gpu-acceleration)
BibTeX
@misc{asof_clm_9617DFAFDF30,
author = {AsOf},
title = {Nvidia partnership: Life Technologies Corporation},
year = {2012},
howpublished = {\url{https://asof.is/claim/clm_9617DFAFDF30}},
note = {Claim clm\_9617DFAFDF30, as of 2012-10-31; source: https://nvidianews.nvidia.com/news/new-gene-sequencer-to-break-1-000-cost-barrier-with-nvidia-tesla-gpu-acceleration},
urldate = {2026-11-20}
}On the record
/claim/clm_9617DFAFDF30.md/v1/claims/clm_9617DFAFDF30submit a correction